Press Release: Santhera Announces Corporate -3-
Werte in diesem Artikel
with the contemplated transaction described in this publication, may not
be publicly offered, directly or indirectly, in Switzerland within the
meaning of the Swiss Financial Services Act ("FinSA"). Neither this
communication nor any other information material relating to the
securities referred to in this publication constitutes advertisement
within the meaning of the FinSA or a prospectus pursuant to the FinSA,
and no such prospectus has been or will be prepared for or in connection
with the transaction described in this publication.
This publication does not constitute an offer to sell, or a solicitation
of an offer to purchase, any securities in the United States. The
securities of Santhera Pharmaceuticals Holding AG to which these
materials relate have not been and will not be registered under the
United States Securities Act of 1933, as amended (the "Securities Act"),
and may not be offered or sold in the United States absent registration
or an applicable exemption from, or in a transaction not subject to, the
registration requirements of the Securities Act. There will not be a
public offering of securities in the United States.
This publication may contain certain forward-looking statements
concerning Santhera Pharmaceuticals Holding AG and its business. Such
statements involve certain risks, uncertainties and other factors which
could cause the actual results, financial condition, performance or
achievements of Santhera Pharmaceuticals Holding AG to be materially
different from those expressed or implied by such statements. Readers
should therefore not place undue reliance on these statements,
particularly not in connection with any contract or investment decision.
Santhera Pharmaceuticals Holding AG disclaims any obligation to update
these forward-looking statements.
# # #
Attachment
-- 2021 02 16_SannCorpUpdate_e_final
https://ml-eu.globenewswire.com/Resource/Download/cde220d6-79b2-4dd7-85e5-54b58bc5f76f
(END) Dow Jones Newswires
February 16, 2021 01:00 ET (06:00 GMT)
Ausgewählte Hebelprodukte auf Santhera Pharmaceuticals
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Santhera Pharmaceuticals
Der Hebel muss zwischen 2 und 20 liegen
Aktuelle Santhera Pharmaceuticals Aktie News
Santhera Pharmaceuticals Analysen
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Santhera Pharmaceuticals nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen
| Datum | Rating | Analyst | |
|---|---|---|---|
| 28.02.11 | Santhera Pharmaceuticals hold | Vontobel Research | |
| 18.02.11 | Santhera Pharmaceuticals hold | Vontobel Research | |
| 08.02.11 | Santhera Pharmaceuticals hold | Vontobel Research | |
| 25.10.10 | Santhera Pharmaceuticals hold | Vontobel Research | |
| 14.10.10 | Santhera Pharmaceuticals hold | Vontobel Research |